Medical Conference Presentations
Data presentations at major medical congresses (ASCO, AHA, AAN and more) where detailed trial results are unveiled to the scientific community.
July 20263
December 20261
About Medical Conference Presentations
Medical conference catalysts are scheduled presentations of clinical data at major congresses — ASCO and ESMO in oncology, AHA and ACC in cardiology, AAN in neurology, and dozens more. They are where the detailed results behind an earlier topline readout are finally shown.
Abstracts are typically released days to weeks ahead of the session, and the full presentation — subgroup analyses, safety detail, curves — can shift a stock even when the headline result was already known.
Why Conferences matter to investors
Conferences turn “topline” numbers into a full picture, and the details often matter: a durable response curve or a clean safety profile can extend a rally, while disappointing subgroups can unwind one. Abstract-release dates and presentation slots are therefore tracked as discrete catalysts.
Frequently asked questions
Why are medical conference presentations catalysts?
They reveal the detailed data behind a trial — efficacy curves, subgroups, safety — which can move a stock even after a topline result, for better or worse.
When are conference abstracts released?
Major congresses usually publish abstracts days to weeks before the sessions, creating an early catalyst ahead of the live presentation.
Which medical conferences matter most for biotech?
It depends on the disease area — ASCO/ESMO for oncology, AHA/ACC for cardiology, AAN for neurology, ADA for diabetes, among others.